Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma

MLA

Laurens G. L. Sand, et al. “Fluorescent CXCR4 Targeting Peptide as Alternative for Antibody Staining in Ewing Sarcoma.” BMC Cancer, vol. 17, no. 1, May 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-017-3352-z.

APA

Laurens G. L. Sand, Tessa Buckle, Fijs W. B. van Leeuwen, Willem E. Corver, Alwine B. Kruisselbrink, Aart G. Jochemsen, Pancras C. W. Hogendoorn, & Károly Szuhai. (2017). Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma. BMC Cancer, 17(1), 1–9. https://doi.org/10.1186/s12885-017-3352-z

Chicago

Laurens G. L. Sand, Tessa Buckle, Fijs W. B. van Leeuwen, Willem E. Corver, Alwine B. Kruisselbrink, Aart G. Jochemsen, Pancras C. W. Hogendoorn, and Károly Szuhai. 2017. “Fluorescent CXCR4 Targeting Peptide as Alternative for Antibody Staining in Ewing Sarcoma.” BMC Cancer 17 (1): 1–9. doi:10.1186/s12885-017-3352-z.